Shares of Fresenius Medical Care AG & Co. (Pref) (ETR:FME) have received an average rating of “Hold” from the twenty analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is €88.39 ($103.98).

Several research analysts recently weighed in on FME shares. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) target price on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Monday, June 12th. Citigroup Inc. set a €92.00 ($108.24) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, June 9th. Kepler Capital Markets set a €95.00 ($111.76) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, June 9th. S&P Global set a €95.00 ($111.76) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, June 9th. Finally, Berenberg Bank set a €95.00 ($111.76) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, June 9th.

COPYRIGHT VIOLATION NOTICE: “Fresenius Medical Care AG & Co. (Pref) (FME) Given Average Rating of “Hold” by Analysts” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/10/04/fresenius-medical-care-ag-co-pref-fme-given-average-rating-of-hold-by-analysts.html.

Fresenius Medical Care AG & Co. (FME) traded up 1.175% on Wednesday, reaching €85.188. The company’s stock had a trading volume of 1,907 shares. Fresenius Medical Care AG & Co. has a 1-year low of €70.82 and a 1-year high of €89.07. The firm’s 50 day moving average price is €80.56 and its 200-day moving average price is €81.94. The company has a market capitalization of €26.14 billion and a price-to-earnings ratio of 21.967.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Stock Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related stocks with our FREE daily email newsletter.